Article
Licensed
Unlicensed
Requires Authentication
Intellectual Property Right Protection for Biomedicines in China
-
Tang Chun
Published/Copyright:
December 1, 2008
Abstract
Intellectual property right (IPR) protection for biomedicines is vitally important in China as China is now one of the largest biomedicine manufacturing countries in the world. This paper discusses the main IPR protection system of biomedicines in China which is composed of a patent system, a new medicine monitor system and a new medicine administrative protection system. We also point out that the trend of the development of the IPR system in China is to gradually reduce the administrative protection of biomedicines and to enhance reforms of international patent protection.
Published Online: 2008-12-01
Published in Print: 2008-August
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Editorial
- Arbitration Clauses in Biotechnology Related Contracts from a Hong Kong Institutional Perspective
- Key Themes in the Policy Debate on Human Genetic Research and Genetic Databanks: An Evaluation
- Intellectual Property Right Protection for Biomedicines in China
- Neuroprosthetics and Medicare Reimbursement
- Genetic Information Nondiscrimination Act of 2008 (Part I). Congress of the United States of America, Washington D.C.
- The Introduction of a Statutory Experimental Use Exemption in New Zealand: Evidence of a Need for Change
- Dariusch Atighetchi, Islamic Bioethics: Problems and Perspectives
Articles in the same Issue
- Editorial
- Arbitration Clauses in Biotechnology Related Contracts from a Hong Kong Institutional Perspective
- Key Themes in the Policy Debate on Human Genetic Research and Genetic Databanks: An Evaluation
- Intellectual Property Right Protection for Biomedicines in China
- Neuroprosthetics and Medicare Reimbursement
- Genetic Information Nondiscrimination Act of 2008 (Part I). Congress of the United States of America, Washington D.C.
- The Introduction of a Statutory Experimental Use Exemption in New Zealand: Evidence of a Need for Change
- Dariusch Atighetchi, Islamic Bioethics: Problems and Perspectives
